Sociedad Americana de Hirudoterapia

Dirección General de Medicamentos, Alimentos y Productos Sanitarios — República Dominicana

DIGEMAPS · Dominican Republic · latin america

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Dominican Republic's Directorate General of Medicines, Food and Health Products (Ministerio de Salud Pública) — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
latin america
Country
Dominican Republic
Leech status
unregulated
Last ASH review
2026-05-27

Relevant Regulation Codes

  • Dominican Ley General de Salud (Ley 42-01)
  • Dominican Ley de Medicamentos (Ley 50-88)
  • Dominican national medical device regulatory framework

Prescriber Requirements

  • Dominican Colegio Médico–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

DIGEMAPS registration as applicable; Spanish-language labelling required by national law. Standard cold-chain conditions, with logistical constraints typical of Caribbean island distribution.

Import/Export Rules

DIGEMAPS and Ministry of Agriculture clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Sistema Dominicano de Seguridad Social (SDSS) and Seguro Familiar de Salud (SFS) coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Caribbean regulatory frameworks rely on a mixture of national and regional cooperation; whether this captures live-organism medical devices has not been independently mapped by ASH.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.